MYC and neoplasm: Two key groups of MYC synthetic lethal targets are regulators of MYC transcription (e.g., BRD4 and CDK9) and MYC stability (e.g., aurora kinases A and B, and polo‐like kinase 1), regulating the levels of MYC in tumor cells.3, 10, 11, 12, 13